iSpecimen Inc.

Public

United StatesHealthcarehttps://www.ispecimen.com/

iSpecimen Inc. is now publicly traded

The data on this page reflects iSpecimen Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

May 14, 2026

Total Funding Raised

$2.5M

Company Overview

iSpecimen Inc. is a healthcare technology company that operates an online marketplace connecting life science researchers with providers of human biospecimens.

Sector

Healthcare

AI Layer

Non-AI

Keywords

biospecimen marketplacehuman biospecimensbiospecimen procurementvirtual biobankcustom specimen collectionprospective collectionpatient samplesclinical samplesbiobank networkhuman tissue sampleshuman biofluidsimmune cellsin-vitro diagnosticsIVDtwo-sided marketplace

iSpecimen Inc. Comparables

Compare iSpecimen Inc. with similar companies based on industry and business-model similarity.

iSpecimen Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Audubon Bioscience	77%
Boca Biolistics	70%

View all Comparables

iSpecimen Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	May 14, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Robert Bradley Lim

Chief Executive Officer

Executive Team

Tracy Curley

Chief Executive Officer and Chief Financial Officer

Executive Team

iSpecimen Inc. Filings

Explore SEC and related filing metadata, where available.

iSpecimen Inc. filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersUnited States

Employee Range22

Year Founded2009

Last FundingMay 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?